FindTrial
Sign In

Estimation of the number of cases of increase in gastric volume using scan in patients who are paralysed and unconscious using high flow nasal oxygen - a before and after procedure study.

Assessment of incidence of gastric insufflation using Ultrasound in anaesthetised and paralysed patients receiving Transnasal Humidified Rapid Insufflation Ventilatory Exchange (THRIVE)- a Pre and Post Intervention Study.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/09/028077
Enrollment
138
Registered
2020-09-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R50-R69- General symptoms and signs

Interventions

Intervention1: Transnasal Humididfied Rapid Insufflation Ventilatory Exchange (THRIVE): Here,THRIVE is used to deliver humidified oxygen through specialised nasal cannulas at high flow rates of about

Sponsors

Jawaharlal Institute of Post graduate Medical Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA 1 and 2 patients, aged more than 18yrs, planned to undergo elective surgery under general anaesthesia.

Exclusion criteria

Exclusion criteria: 1.Patients planned to undergo Rapid sequence induction. 2.Patients planned to undergo awake intubation. 3.Patients with facial fractures. 4.Pregnant patients planned for general anesthesia. 5.Patients with predicted airway difficulty. 6.Patients with BMI >30.

Design outcomes

Primary

MeasureTime frame
To assess the incidence of gastric insufflation associated with Transnasal Humidified Rapid Insufflation Ventilatory Exchange in anaesthetised and paralysed patients by the appearance of comet tail artifacts.Timepoint: The appearance of comet tail artifacts in gastric ultrasound after intubation.—

Secondary

MeasureTime frame
1.To measure gastric antral area prior to and following insufflation. 2.To measure the end tidal carbon dioxide values before and after intubation. 3.To measure any episodes of desaturation (Sp02 92%) during the time of insufflation Timepoint: 1.Gastric area assessment before and after intubation 2.Measurement of etCO2 before and after intubation 3.Any incidence of desaturation during the procedure will be noted.—

Countries

India

Contacts

Public ContactDr Jeevasri C

JIPMER

priyaab8@gmail.com8903477132

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026